Exelixis Inc (EXEL)
34.83
+0.18
(+0.52%)
USD |
NASDAQ |
Nov 21, 16:00
34.82
0.00 (0.00%)
After-Hours: 20:00
Exelixis Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.9465 |
| December 31, 2016 | 2.117 |
| September 30, 2016 | 5.960 |
| June 30, 2016 | -2.128 |
| March 31, 2016 | -2.492 |
| December 31, 2015 | -2.968 |
| September 30, 2015 | -5.091 |
| June 30, 2015 | -1.973 |
| March 31, 2015 | -2.510 |
| December 31, 2014 | -3.109 |
| September 30, 2014 | -6.071 |
| June 30, 2014 | 107.61 |
| March 31, 2014 | 4.799 |
| December 31, 2013 | 5.242 |
| September 30, 2013 | 2.573 |
| June 30, 2013 | 1.712 |
| March 31, 2013 | 1.298 |
| December 31, 2012 | 1.133 |
| September 30, 2012 | 0.9837 |
| June 30, 2012 | 1.844 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
--
Maximum
Dec 2019
--
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Merck & Co Inc | 0.8568 |
| ADMA Biologics Inc | 0.437 |
| Vericel Corp | 0.00 |
| Catalyst Pharmaceuticals Inc | 0.00 |
| Inovio Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.960B |
| Total Liabilities (Quarterly) | 684.86M |
| Shareholders Equity (Quarterly) | 2.275B |
| Current Ratio | 3.930 |